Name: Niagen Bioscience, Inc. (NAGE) Balance Sheet
Creator: FinSpry

Niagen Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Niagen Bioscience, Inc. (NAGE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	44.51	27.17	20.29	28.02	16.50	18.81	22.42
Cash & Short-Term Investments	44.51	27.17	20.29	28.02	16.50	18.81	22.42
Accounts Receivable	7.77	5.23	8.48	5.23	2.69	2.18	4.42
Inventory	9.19	14.53	14.68	13.60	11.68	11.54	8.25
Other Current Assets	2.48	2.45	2.97	1.86	1.15	2.18	0.00
Total Current Assets	64.10	49.53	46.57	48.91	32.22	33.52	36.53
Non-Current Assets
Property, Plant & Equipment (Net)	3.45	4.54	6.32	7.36	4.43	4.66	3.59
Intangible Assets	0.36	0.51	0.67	0.86	1.08	0.00	0.00
Other Non-Current Assets	0.37	0.38	0.50	0.72	0.63	0.76	0.57
Total Non-Current Assets	4.18	5.43	7.49	8.98	6.11	6.73	5.70
Total Assets	68.28	54.96	54.06	57.84	38.36	40.25	42.23
Current Liabilities
Accounts Payable	8.53	10.23	17.02	10.42	9.45	14.04	13.99
Short-Term Debt	1.99	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	7.82	9.49	7.34	6.48	6.13	0.00	0.00
Deferred Revenue	0.61	0.20	0.16	0.16	0.28	0.00	0.00
Other Current Liabilities	6.82	15.85	18.00	23.21	0.28	0.17	0.00
Total Current Liabilities	17.95	20.62	17.87	17.61	16.48	15.06	14.44
Non-Current Liabilities
Long-Term Debt	1.66	2.58	3.56	4.15	1.02	0.87	0.14
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	1.79	0.00
Total Non-Current Liabilities	4.24	5.89	7.52	8.50	5.46	4.74	0.61
Total Liabilities	22.18	26.51	25.39	26.11	21.93	19.80	15.05
Stockholders' Equity
Common Stock	0.08	0.08	0.07	0.07	0.06	0.00	0.00
Retained Earnings	-181.91	-190.46	-185.49	-168.95	-141.83	-121.90	-89.75
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	227.93	218.85	214.09	200.61	158.19	142.29	116.88
Shares Outstanding	77.33	74.98	74.57	68.13	0.00	0.00	0.00
Total Stockholders' Equity	46.09	28.46	28.67	31.73	16.42	20.45	27.18
Total Liabilities & Equity	68.28	54.96	54.06	57.84	38.36	40.25	42.23